Vanguard Personalized Indexing Management LLC Has $1.04 Million Stock Position in DENTSPLY SIRONA Inc. $XRAY

Vanguard Personalized Indexing Management LLC increased its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 189.4% in the 2nd quarter, HoldingsChannel reports. The firm owned 65,315 shares of the medical instruments supplier’s stock after acquiring an additional 42,747 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in DENTSPLY SIRONA were worth $1,037,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in XRAY. Wealth Enhancement Advisory Services LLC grew its stake in DENTSPLY SIRONA by 39.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,903 shares of the medical instruments supplier’s stock worth $805,000 after purchasing an additional 15,117 shares during the period. Janney Montgomery Scott LLC grew its stake in DENTSPLY SIRONA by 210.5% in the first quarter. Janney Montgomery Scott LLC now owns 64,191 shares of the medical instruments supplier’s stock valued at $959,000 after acquiring an additional 43,516 shares during the period. Blue Trust Inc. grew its stake in DENTSPLY SIRONA by 57.7% in the first quarter. Blue Trust Inc. now owns 12,554 shares of the medical instruments supplier’s stock valued at $188,000 after acquiring an additional 4,595 shares during the period. Lecap Asset Management Ltd. acquired a new stake in DENTSPLY SIRONA in the first quarter valued at approximately $761,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in DENTSPLY SIRONA in the first quarter valued at approximately $25,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have commented on XRAY. Barrington Research reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, August 8th. UBS Group reduced their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research note on Friday, August 8th. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus price target of $18.00.

DENTSPLY SIRONA Stock Down 0.9%

Shares of NASDAQ:XRAY opened at $12.51 on Friday. The stock has a market cap of $2.50 billion, a price-to-earnings ratio of -2.64, a PEG ratio of 0.78 and a beta of 0.96. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. DENTSPLY SIRONA Inc. has a 12-month low of $11.69 and a 12-month high of $24.86. The business’s 50 day moving average is $13.38 and its 200 day moving average is $14.51.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million for the quarter, compared to analysts’ expectations of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 10th. Investors of record on Friday, September 26th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.